medigraphic.com
Academia Mexicana de Neurología, A.C.

2009, Número 2

<< Anterior Siguiente >>

Rev Mex Neuroci 2009; 10 (2)


Distonías de los miembros y calambre del escribano: uso de toxina botulínica tipo A

Lester NJ, Zúñiga RC

Idioma: Español
Referencias bibliográficas: 13
Paginas: 103-106
Archivo PDF: 40.48 Kb.


FRAGMENTO

Las distonías de miembros son movimientos involuntarios caracterizados por una contracción muscular repetitiva con posturas de torsión, bizarras, que se asocian a fenómenos de co-contracción muscular y sobreflujo (overflow).


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Defazio G, Abbruzzese G, Livrea P, Berardelli A. Epidemiology of primary dystonia. Lancet Neurol 2004; 3: 673-8.

  2. Defazio G, Berardelli A, Hallett M. Do primary adult-onset focal dystonias share aetiological factors? Brain 2007; 30: 1183-93.

  3. Das CP, Dressler D, Hallett M. Botulinum toxin therapy of writer’s cramp. Eur J Neurol 2006; 13(Suppl. 1): 55-9.

  4. Sheean G. Limb and occupational dystonia. In: Moore P, Naumann N (eds.). Handbook of botulinum toxin treatment. 2nd Ed. Blackwell Science; 2003, p. 195-217.

  5. Comella CL, Pullman SL. Botulinum toxin in neurological disease. Muscle Nerve 2004; 29: 628-44.

  6. Papapetropoulos S, Singer C. Botulinum toxin in movement disorders. Semin Neurol 2007; 27: 183-94.

  7. Yoshimura DM, Aminoff MJ, Olney RK. Botulinum toxin therapy for limb dystonias. Neurology 1992; 42: 627-30.

  8. Tsui JK, Bhatt M, Calne S, Calne DB. Botulinum toxin in the treatment of writer’s cramp: a double-blind study. Neurology 1993; 43: 183-5.

  9. Cole R, Hallett M, Cohen LG. Double-blind trial of botulinum toxin for treatment of focal hand dystonia. Mov Disord 1995; 10: 466- 71.

  10. Wissel J, Kabus C, Wenzel R, Klepsch S, Schwarz U, Nebe A, et al. Botulinum toxin in writer’s cramp: objective response evaluation in 31 patients. J Neurol Neurosurg Psychiatry 1996; 61: 172-5.

  11. Contarino MF, Kruisdijk JJM, Koster L, Ongerboer de Visser BW, Speelman JD, Koelman JHTM. Sensory integration in writer’s cramp: comparison with controls and evaluation of botulinum toxin effect. Clin Neurophysiol 2007; 118: 2195-206.

  12. Kruisdijk JJ, Koelman JH, Ongerboer de Visser BW, de Haan RJ, Speelman JD. Botulinum toxin for writer’s cramp: a randomized, placebo-controlled trial and 1-year follow-up. J Neurol Neurosurg Psychiatry 2007; 78: 264-70.

  13. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D, for the Methods Work Group, Third U.S. Preventive Services Task Force. Current methods of the U.S. Preventive Services Task Force: a review of the process. Am J Prev Med 2001; 20: 21-35.




2020     |     www.medigraphic.com